Clinical Trial Update: A Gene Therapy Study for Hemophilia B [Phase 2]

View source ↗

Summary

Phase 2 gene therapy trial for Hemophilia B completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: Pfizer | Conditions: Hemophilia B | Phase 2 | Status: COMPLETED | Results posted: 2020-05-19